Selexipag treatment in patients with systemic sclerosis–associated pulmonary arterial hypertension in clinical practice, a case series

OBJECTIVE: To describe the efficacy and safety in all patients with systemic sclerosis–associated pulmonary arterial hypertension who started selexipag between 09-2016 and 06-2018 in two pulmonary arterial hypertension expert centers. METHODS: All patients with systemic sclerosis–associated pulmonar...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemmers, Jacqueline MJ, Fretheim, Håvard, Knaapen, Hanneke KA, van den Hoogen, Frank HJ, van Haren-Willems, Jolanda HGM, Duijnhouwer, Anthony L, van Dijk, Arie P, van den Ende, Cornelia HM, Hoffmann-Vold, Anna-Maria, Vonk, Madelon C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922617/
https://www.ncbi.nlm.nih.gov/pubmed/35382522
http://dx.doi.org/10.1177/2397198320916082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922617/
https://www.ncbi.nlm.nih.gov/pubmed/35382522
http://dx.doi.org/10.1177/2397198320916082

Ejemplares similares